<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-183 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-183</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-183</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-7.html">extraction-schema-7</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <p><strong>Paper ID:</strong> paper-35b7b967d421550d0fbfcd374180037594e42757</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/35b7b967d421550d0fbfcd374180037594e42757" target="_blank">Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease</a></p>
                <p><strong>Paper Venue:</strong> Neurobiology of Aging</p>
                <p><strong>Paper TL;DR:</strong> The cellular, synaptic, and biochemical composition of midfrontal cortices in female subjects from the Religious Orders Study is compared and novel biochemical targets that may be associated with resilient cognitive brain aging in the setting of pathological AD are identified.</p>
                <p><strong>Cost:</strong> 0.014</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e183.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e183.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Astrocytes (GFAP+)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Astrocytes immunolabeled with glial fibrillary acidic protein (GFAP)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Cortical astrocytes identified by GFAP immunohistochemistry; implicated by the authors as associated with preserved cognition despite high AD pathology (i.e., a putative resilience-associated glial response).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Cellular, synaptic and biochemical features of resilient cognition in Alzheimer’s disease</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>astrocyte</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>resilient</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>GFAP+ astrocyte densities in midfrontal cortex were significantly increased in the AD-Resilient group (mean 402/mm2 ±117) compared to AD-Dementia (276/mm2 ±114) and Normal Comparison (238/mm2 ±115); ANOVA F(2,27)=5.3, p=0.011 with post-hoc AD-Resilient vs AD-Dementia p=0.02 and vs Normal p=0.005.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Authors speculate an ameliorative (protective) role for astroglial activation: structural/biochemical support to neurons and endothelium, maintenance of extracellular ion balance and nutrients, regulation of blood flow, neurotransmitter uptake/release, modulation of synaptic transmission, and provision of trophic/detoxifying support; described as a context-specific reactive astrocyte phenotype associated with resilience. Proteomic hits (e.g., increased IL-3, transcription factor 3) are suggested as potential mediators but require validation.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem midfrontal cortex (Brodmann area 46) from female participants in the Religious Orders Study; GFAP immunohistochemistry and semi-quantitative image analysis.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Pathological AD with normal cognition (preclinical/asymptomatic pathological AD — termed AD-Resilient in the paper).</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>The paper notes limited prior data and heterogeneity in the literature; some earlier reports described similarities between preclinical/resilient cases and AD with dementia rather than increased astrocytic responses. The authors emphasize that reactive astrocyte responses are diverse and context-dependent and that their observations are correlational and may not indicate causality.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease", 'publication_date_yy_mm': '2013-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e183.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e183.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Postsynaptic spines (synaptopodin+)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Dendritic spines labeled by synaptopodin immunohistochemistry</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Synaptopodin-immunoreactive puncta marking postsynaptic/ spine apparatus; used as a quantitative marker of postsynaptic spine density and plasticity.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Cellular, synaptic and biochemical features of resilient cognition in Alzheimer’s disease</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>postsynaptic dendritic spine (neuronal compartment)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>resilient</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Synaptopodin-labeled spine densities were preserved in the AD-Resilient group (mean ≈ 18,997/mm2 ±11,431) and comparable to Normal Comparison (≈24,426/mm2 ±9,006), whereas AD-Dementia showed lower densities (≈8,904/mm2 ±10,342); ANOVA F(2,27)=5.6, p=0.009, post-hoc AD-Resilient vs AD-Dementia p=0.04 and AD-Dementia vs Normal p=0.003.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Synaptic preservation likely reflects maintained connectivity and plasticity; synaptopodin is an actin-associated spine protein central to LTP and spine structural integrity. The authors link synaptic vulnerability to accumulation of amyloid-β and tau (negative correlations reported) and propose that differential protein expression (e.g., increased APP-binding protein, increased IL-3) in AD-Resilient cases may contribute to synaptic resilience.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem midfrontal cortex; high-magnification synaptopodin immunohistochemistry with systematic sampling and automated counting.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Pathological AD with normal cognition (preclinical/resilient) versus AD with clinical dementia.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Prior literature is mixed: some studies find reductions of synaptopodin in AD, while others report intermediate or variable presynaptic/postsynaptic protein changes in preclinical/early AD. The current study is correlative and limited to one cortical region and a modest sample size.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease", 'publication_date_yy_mm': '2013-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e183.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e183.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Presynaptic terminals (synaptophysin+)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Presynaptic terminals immunolabeled for synaptophysin</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Synaptophysin immunoreactivity used as a marker of presynaptic vesicle density/innervation and synaptic integrity; preserved in resilient cases and reduced in AD dementia cases.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Cellular, synaptic and biochemical features of resilient cognition in Alzheimer’s disease</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>presynaptic terminal (neuronal compartment)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>resilient</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Synaptophysin optical density (OD) in midfrontal cortex was preserved in AD-Resilient (mean OD 1314 ±217) and reduced in AD-Dementia (1091 ±276); ANOVA F(2,27)=6.7, p=0.004 with post-hoc AD-Resilient vs AD-Dementia p=0.04 and AD-Dementia vs Normal p=0.001. Pre- and postsynaptic measures were highly correlated (Spearman r=0.58, p=0.0009).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Synaptic loss is linked to amyloid-β and tau accumulation (negative correlations with both Aβ and PHFtau reported); preserved synaptophysin suggests maintained connectivity which may underlie resilient cognition. Proteomic differences (e.g., increased APP-binding protein, altered kinase/phosphatase levels) are proposed as candidate molecular contributors to synaptic preservation.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem midfrontal cortex; synaptophysin immunohistochemistry quantified as optical density across cortical gray matter.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Pathological AD with normal cognition (AD-Resilient) contrasted with AD with clinical dementia.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Other studies show variable changes in presynaptic proteins in preclinical/early AD; not all presynaptic markers behave identically, and prior reports differ by brain region and disease stage. The authors note synaptic loss is widely reported as the best neuropathologic correlate of dementia, but that preservation can be seen in resilient individuals.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease", 'publication_date_yy_mm': '2013-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e183.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e183.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Neurons (NeuN+)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Cortical neurons immunolabeled with NeuN</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Neurons counted via NeuN immunohistochemistry; in this study neuronal densities did not differ significantly across groups, though correlations suggest some vulnerability associated with amyloid burden.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Cellular, synaptic and biochemical features of resilient cognition in Alzheimer’s disease</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>neurons (cortical neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>unclear</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Group comparisons showed no significant differences in NeuN neuron densities among AD-Resilient, AD-Dementia and Normal Comparison groups (means: AD-Resilient 445/mm2, AD-Dementia 448/mm2, Normal 562/mm2; F(2,27)=2.4, p=0.11). However, amyloid-β plaque burden correlated negatively with NeuN density (Spearman ρ = -0.39, p=0.03), suggesting neuronal vulnerability associated with Aβ.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Possible vulnerability linked to amyloid-β and tau pathology (negative correlations reported); authors caution that density measures may not reflect total number because atrophy/volume loss can confound density estimates. Other studies report neuronal hypertrophy in some asymptomatic AD cases, indicating heterogeneity.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem midfrontal cortex; NeuN immunohistochemistry and automated profile counting.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Pathological AD with and without clinical dementia (both AD-Resilient and AD-Dementia groups included).</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Some prior studies (cited in the paper) report preserved or even hypertrophied neurons in asymptomatic AD, while others report neuronal loss associated with clinical AD; the authors emphasize methodological caveats (density vs total counts) and heterogeneity across brain regions and cohorts.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease", 'publication_date_yy_mm': '2013-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment <em>(Rating: 2)</em></li>
                <li>Neuronal hypertrophy in asymptomatic Alzheimer disease <em>(Rating: 2)</em></li>
                <li>Differential loss of synaptic proteins in Alzheimer’s disease: implications for synaptic dysfunction <em>(Rating: 2)</em></li>
                <li>Amyloid load and neural elements in Alzheimer’s disease and nondemented individuals with high amyloid plaque density <em>(Rating: 2)</em></li>
                <li>Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans <em>(Rating: 2)</em></li>
                <li>Hippocampal neurons in pre-clinical Alzheimer’s disease <em>(Rating: 2)</em></li>
                <li>Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>